COVID-19

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 | Association of Nirmatrelvir–ritonavir with Post-acute Sequelae and Mortality in Patients |
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization |
Cognitive Profile in Multiple Sclerosis and Post-COVID Condition | Unravelling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID |
Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021

COVID-19 Booster Vaccine Uptake and Reduced Risks for Long-COVID |
COVID-19 Immunologic Antiviral Therapy with Omalizumab (CIAO)—a Randomized Controlled Clinical Trial | Abatacept Pharmacokinetics and Exposure Response in Patients |
The Gut Microbiome Associates with Phenotypic Manifestations |
Characteristics and Determinants of Pulmonary Long COVID |
Long COVID: Plasma Levels of Neurofilament Light Chain in Mild COVID-19 Patients with Neurocognitive Symptoms

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 | Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen |
The Persistence of SARS-CoV-2 in Tissues and its Association with Long COVID Symptoms: A Cross-sectional Cohort Study in China

Systematic Analyses of the Factors Influencing Sperm Quality in Patients with SARS-CoV-2 Infection |
Nirmatrelvir/ritonavir and Remdesivir against Symptomatic Treatment in High-risk COVID-19 Outpatients to Prevent Hospitalization or Death During the Omicron Era: A Propensity Score-matched Study |
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 |
Brain and Cognitive Changes in Patients with Long COVID Compared with Infection-recovered Control Subjects | Incident Allergic Diseases in Post-COVID-19 Condition: Multinational Cohort Studies from South Korea, Japan and the UK |
Functional Limitations and Exercise Intolerance in Patients with Post-COVID Condition

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease |
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs |
Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment – A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study |
Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial |
Prevalence of Orthostatic Intolerance in Long COVID Clinic Patients and Healthy Volunteers: A Multicenter Study | Autonomic Cardiac Function in Children and Adolescents with Long COVID: A Case-controlled Study | Iron Dysregulation and Inflammatory Stress Erythropoiesis Associates with Long-term Outcome of COVID-19

Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults |
Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform |
Cognition and Memory after COVID-19 in a Large Community Sample |
Prospective Memory Assessment Before and After Covid-19 |
What is the Impact of Long-term COVID-19 on Workers